Position in LLY
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$9,199,539
-$1,256,023 QoQ
Shares Held
10,002
+2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GM Advisory Group, LLC holds $19,630,085 across 10 Drug Manufacturers - General names. LLY ranks #1 (46.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
10,002 | $9,199,539 | |
| 2 | JNJ |
Johnson & Johnson
|
14,495 | $3,543,157 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,762 | $2,136,590 | |
| 4 | ABBV |
AbbVie Inc.
|
7,400 | $1,609,426 | |
| 5 | PFE |
Pfizer Inc
|
32,594 | $915,239 | |
| 6 | AMGN |
Amgen Inc
|
2,556 | $899,328 | |
| 7 | AZN |
Astrazeneca PLC
|
2,421 | $477,469 | |
| 8 | NVS |
Novartis AG
|
2,102 | $321,080 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,199,539 | 10,002 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $10,455,562 | 9,729 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,235,352 | 12,104 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $9,923,416 | 12,730 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,859,713 | 11,938 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,789,992 | 11,386 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $9,735,594 | 10,989 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $9,692,092 | 10,705 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,258,823 | 10,616 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,927,130 | 10,168 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $5,655,441 | 10,529 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,144,241 | 10,969 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,238,833 | 12,343 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,110,578 | 11,236 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,633,160 | 11,236 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,643,048 | 11,236 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,786,093 | 9,729 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,787,336 | 10,091 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,275,149 | 9,847 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,386,319 | 10,397 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,119,472 | 11,345 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,011,897 | 11,916 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,507,287 | 10,183 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,671,844 | 10,183 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,983,696 | 14,300 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||